CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 77 enrolled
Drug / intervention
ingenol mebutate gel 0.015% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02716714
NCT02716714Phase 4Completed
CompareCT.gov

A Multi-center, OPen, InvEstigator Initiated Phase IV Clinical TRial to Evaluate the Efficacy and SaFety of Ingenol Mebutate Gel 0.015% on Face and Scalp & 0.05% on Trunk and Extremities in KorEan Patient With ACtinic KeraTosis (PERFECT)

Korea University·interventional·Posted Mar 23, 2016·Updated Apr 18, 2018

In Brief

A Phase 4 clinical trial evaluating ingenol mebutate gel 0.015% and ingenol mebutate gel 0.05% for Actinic Keratosis. Completed, enrolled 77 participants across 1 site.

Detailed Summary

This study evaluate the efficacy and safety of ingenol mebutate gel 0.015% on face and scalp \& 0.05% on trunk and extremities in Korean patient with actinic keratosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Keratosis
CountriesSouth Korea
CollaboratorsLEO Pharma, Chonnam National University Hospital, Severance Hospital, Ajou University School of Medicine, Asan Medical Center, Samsung Medical Center, Seoul National University Bundang Hospital, Dong-A University Hospital, Korea University Anam Hospital, Seoul National University Hospital

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 23, 2016
Enrollment StartApr 1, 2015
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.3 years ago

Interventions

ingenol mebutate gel 0.015%drug

-Face or Scalp arm (Referred to Face/Scalp arm): Apply ingenol mebutate gel 0.015% once daily for 3 consecutive days

ingenol mebutate gel 0.05%drug

-Trunk or Extremities arm (Referred to Trunk/Extremities arm): Apply ingenol mebutate gel 0.05% once daily for 2 consecutive days